AZT + 3TC in Pregnancy
Combination therapy with AZT and 3TC was more effective in reducing perinatal transmission than AZT alone; however, 3TC treatment was associated with high rates of hematologic toxicity in newborns and development of 3TC-associated resistance mutations in mothers.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)